Abstract JAK2 (Janus kinase-2) is activated by cell shrinkage and may thus participate in cell volume regulation. Cell volume regulatory ion channels include the small conductance Cl -channels ClC-2. The present study thus explored whether JAK2 influences ClC-2 activity. To this end, ClC-2 was expressed in Xenopus oocytes with or without wild type JAK2, active JAK2 might slow channel protein insertion into rather than accelerating channel protein retrieval from the cell membrane. In conclusion, JAK2 down-regulates ClC-2 activity and thus counteracts Cl -exit, an effect which may impact on cell volume regulation.
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Introduction
Janus-activated kinase-2 JAK2 participates in the signaling of leptin [1] , growth hormone [2] , erythropoietin [3] , thrombopoietin [3] , granulocyte colony-stimulating factor [3] and a variety of cytokines [3, 4] . JAK2 contributes to the signaling of neoplasms and JAK2 inhibitors are considered as drugs in the treatment of myeloproliferative disorders [5] [6] [7] [8] [9] [10] [11] . The gain of function mutation V617F JAK2 is observed in the majority of myeloproliferative diseases [12] . JAK2 is activated by hyperosmotic shock and participates in the stimulation of the Na 
Materials and Methods

Constructs
For generation of cRNA the following cDNA constructs were used: Wild-type human ClC-2 [32] [33] [34] and wild-type human JAK2 (Imagenes, Berlin, Germany). The inactive K882E JAK2 mutant [35] and the gain of function V617F JAK2 mutant [12] were generated by site-directed mutagenesis (QuikChange II XL Site-Directed Mutagenesis Kit; Stratagene, Heidelberg, Germany) as described previously [36] . The following primers were used: Underlined bases indicate mutation sites. Hemagglutinin (HA)-tagged ClC-2 was generated by site-directed mutagenesis [37] . The mutants were sequenced to verify the presence of the desired mutation. The mutants were used for generation of cRNA as described previously [38] .
Voltage clamp in Xenopus oocytes
Xenopus oocytes were prepared as previously described [39] . Wild type JAK2 cRNA or V617F JAK2 or K882E JAK2 cRNA (10 ng) and 15 ng ClC-2 were injected on the first day after preparation of the oocytes [37] . The oocytes were maintained at 17°C in ND96 solution containing (in mM: 96 NaCl, 4 KCl, 1.8 MgC1 2 , 0.1 CaC1 2 , 5 HEPES, pH 7.4). The ND96 solution was supplemented with 100 mg/l gentamycin tetracyclin 50 mg/l, ciprofloxacin 1.6 mg/l theophyllin (90 mg/l) and, where indicated, with AG490 (40 µM final concentration) or brefeldin A (5 µM final concentration). Experiments were performed at room temperature 3 days after injection. The currents were determined in two-electrode voltage-clamp utilizing a pulse protocol of 10 s pulses from -140 mV to +40 mV in 20 mV increments. The intermediate holding-voltage was -60 mV. The current at the end of each voltage step was taken for data analysis. The data were filtered at 2 kHz, and recorded with MacLab digital to analog converter and software for data acquisition and analysis (ADInstruments, Castle Hill, Australia). The control bath solution (ND96) contained 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl 2 , 1 mM MgCl 2 and 5 mM HEPES, pH 7.4. The flow rate of the superfusion was 20 ml/min and a complete exchange of the bath solution was reached within about 10 s.
Detection of ClC-2 cell surface expression by chemiluminescence
To determine ClC-2 cell surface expression by chemiluminescence, defolliculated oocytes were injected with 10 ng cRNA encoding either wild type JAK2 or JAK2-mutant ( V617F JAK2 or K882E JAK2) or with water and at the same day with 15 ng cRNA encoding ClC-2-HA which contains an inserted HA epitope. Oocytes were incubated with 0.5µg/mL primary rat monoclonal anti-HA antibody (clone 3 F10, Roche, Mannheim, Germany) for 2h at room temperature and subsequently with secondary, HRP-conjugated goat anti-rat IgG (H&L) antibody (1:1000, Cell Signaling Technology, MA, USA) for 1 h at room temperature. Post-staining individual oocytes were placed in 96 well plates with 20 µL of SuperSignal ELISA Femto Maximum Sensitivity Substrate (Pierce, Rockford, IL, USA) and chemiluminescence of single oocytes was quantified in a luminometer (Walter Wallac 2 plate reader, Perkin Elmer, Juegesheim, Germany) by integrating the signal over a period of 1 s. The results of the experiments are given as normalized relative light units [40] .
Determination of cell volume in Jurkat cells
The forward scatter in flow cytometric analysis (FACSCalibur from Becton Dickinson) was taken as measure for cell volume [41] . Human Jurkat cells [42] (10 6 cells per ml) were cultured for 16 hours in RPMI 1640 (PAA -15-840) supplemented with 10% FBS, 1% penicillin/streptomycin, HEPES, Lglutamine, sodium-pyruvate, NEAA-non-essential amino acids and β-mercaptoethanol at 37°C in a humidified atmosphere with 5% CO 2 / air in the absence or presence of the JAK2 inhibitor AG490 (40 µM).
Statistical analysis
Data are provided as means ± SEM, n represents the number of oocytes investigated. All experiments were repeated with at least 2-3 batches of oocytes; in all repetitions qualitatively similar data were obtained. Data were tested for significance using ANOVA or t-test, as appropriate. Results with p < 0.05 were considered statistically significant.
Results
The present study explored the effect of JAK2 (Janus kinase-2) on ClC-2 channel. To this end cRNA encoding ClC-2 was injected into Xenopus oocytes with or without cRNA encoding JAK2 and the cell membrane conductance determined utilizing dual-electrode voltageclamp. In water injected oocytes the cell membrane conductance was low (Fig.1) . Expression of ClC-2 was, however, followed by a marked increase of cell membrane conductance. As illustrated in Fig. 1 , the conductance was significantly decreased by additional expression of JAK2. Accordingly, coexpression of JAK2 downregulated ClC-2 activity.
Similar to wild type JAK2, constitutively active mutant V617F JAK2 inhibited ClC-2 activity. Again, the conductance was significantly lower in Xenopus oocytes expressing ClC-2 together with V617F JAK2 than in Xenopus oocytes expressing ClC-2 alone (Fig. 1) . In contrast, the inactive mutant K882E JAK2 did not significantly modify the activity of ClC-2 (Fig. 1) . Treatment of ClC-2 and V617F JAK2 expressing Xenopus oocytes with the JAK2 inhibitor AG490 (40 µM) was followed by a gradual increase of the cell membrane conductance (Fig. 2) . The effect of the inhibitor was slow and reached statistical significance only after 24 hours AG490 treatment.
The down-regulation of ClC-2 activity by JAK2 could have resulted from an influence on the protein abundance in the cell membrane. To explore that possibility, the channel protein abundance in the plasma membrane was determined by chemiluminescence. As illustrated in Fig. 3 , the coexpression of JAK2 and V617F JAK2 significantly decreased the ClC-2 protein abundance within the oocyte cell membrane.
JAK2 could enhance ClC-2 protein abundance by either interference with channel insertion into the cell membrane or by accelerating channel protein retrieval from the cell membrane. To discriminate between these two possibilities, ClC-2 and V617F JAK2 expressing Xenopus oocytes were treated with 5 µM brefeldin A, which disrupts the insertion of new channel protein into the cell membrane. As shown in Fig. 4 , the decline of conductance in the presence of brefeldin A was similar in oocytes expressing ClC-2 with Inhibition of JAK2 is expected to enhance ClC-2 channel activity, thus fostering Cl -exit and decrease of cell volume. Accordingly, an additional series of experiments was performed to elucidate whether AG490 influences cell volume of Jurkat lymphocytes. Cell volume was estimated from forward scatter in flow cytometry. Exposure of Jurkat cells for 16 hours to AG490 (40 µM) slightly but significantly (p<0.05) decreased forward scatter from 486 ± 6 (n = 3) to 467 ± 3 (n = 3).
Discussion
The present observations reveal a novel mechanism in the regulation of the Cl -channel ClC-2. The Janus Kinase 2 decreases the ClC-2 protein abundance in the cell membrane and thus counteracts Cl -exit, an effect resulting from decrease of channel protein abundance in the cell membrane. According to the experiments with brefeldin A, JAK2 might interfere with channel protein insertion rather than accelerating channel protein retrieval from the cell membrane.
JAK2 sensitive down-regulation of ClC-2 may participate in cell volume regulation, as ClC-2 has been shown to be sensitive to cell volume [18] . Cell volume regulaHosseinzadeh/Bhavsar/Lang cellular chloride concentration and thus cell membrane potential of neurons [43] , in the survival of male germ cells and photoreceptors [44] as well as in the pulmonary chloride and water secretion, which is in turn necessary for fetal lung development [45] . Whether those functions are influenced by JAK2 is unknown.
Excessive JAK2 activity has been implicated in tumor cell growth [12] and JAK2 inhibitors have been shown to exert antineoplastic effects in myeloproliferative disorders [5] [6] [7] [8] [9] [10] [11] . Along those lines, the gain of function mutation V617F JAK2 is found in the majority of myeloproliferative diseases [12] . Activation of Cl -channels may promote apoptosis [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] . Whether downregulation of ClC-2 enhances the resistance of lymphoid cells and/or other tumor cells against triggers of apoptosis remains to be shown.
In conclusion, JAK2 down-regulates the cell volume regulatory Cl -channel ClC-2 and may thus contribute to regulation of cell volume and apoptosis. At least in theory, the regulation of chloride channels may play a role in neoplastic effects of the V617F JAK2 mutation. 
